Reuters reveals Buyout fund Ardian makes $1.2 bln swoop on Italy’s Biofarma Group – Reuters News Agency


Reuters broke the news that European private equity firm Ardian has clinched a deal to buy Italian drug firm Biofarma Group for about 1.1 billion euros ($1.26 billion) — its second pharmaceutical deal in less than a year. The transaction will see Ardian expanding in the lucrative dietary supplement market, an industry that has been booming during the COVID-19 pandemic as people have turned to multivitamin products to boost their immunity.

Article Tags

Topics of Interest: DealsHealth

Type: Reuters Best

Sectors: Business & FinancePharmaceuticals & Healthcare

Regions: Europe

Win Types: Speed

Media Types: Text

Customer Impact: Important Regional Story

Source link

Leave a Comment